Western Standard LLC Purchases 1,008,664 Shares of Select Medical Holdings Corporation $SEM

Western Standard LLC increased its position in shares of Select Medical Holdings Corporation (NYSE:SEM) by 95.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,064,021 shares of the health services provider’s stock after buying an additional 1,008,664 shares during the period. Select Medical accounts for approximately 14.1% of Western Standard LLC’s investment portfolio, making the stock its biggest position. Western Standard LLC’s holdings in Select Medical were worth $30,651,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new position in Select Medical during the third quarter worth $27,000. Cornerstone Planning Group LLC increased its holdings in Select Medical by 6,868.4% during the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock worth $51,000 after buying an additional 3,915 shares during the last quarter. First Horizon Corp acquired a new position in Select Medical during the fourth quarter worth $52,000. GAMMA Investing LLC increased its holdings in Select Medical by 147.9% during the fourth quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock worth $70,000 after buying an additional 2,812 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB increased its holdings in Select Medical by 20.9% during the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock worth $74,000 after buying an additional 999 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Trading Up 0.0%

SEM stock opened at $16.44 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. The company’s 50-day simple moving average is $16.23 and its 200 day simple moving average is $15.31. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $16.99. The company has a market capitalization of $2.04 billion, a PE ratio of 15.50, a price-to-earnings-growth ratio of 0.94 and a beta of 1.02.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the company posted $0.44 earnings per share. The company’s revenue was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.27 earnings per share for the current year.

Select Medical announced that its board has authorized a stock buyback program on Thursday, February 19th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to buy up to 49.5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be given a dividend of $0.0625 per share. The ex-dividend date of this dividend is Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio is currently 23.58%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday. Finally, Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $15.63.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.